NEUROCRINE BIOSCIENCES INC Uncategorized Contracts & Agreements

67 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Neurocrine Biosciences, Inc. Inducement Plan, as amended
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2018
Amended and Restated Product Agreement dated June 27, 2017 by and between Patheon UK Limited and the Company
NEUROCRINE BIOSCIENCES INC
Biotechnology
2017
Form of Indemnity Agreement entered into with each of the Companys executive officers and directors
NEUROCRINE BIOSCIENCES INC
Biotechnology
DE
2017
Neurocrine Biosciences, Inc. 12780 El Camino Real San Diego, CA 92130
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2017
NEUROCRINE BIOSCIENCES, INC. INDUCEMENT PLAN ADOPTED: SEPTEMBER 15, 2014 AMENDED: OCTOBER 7, 2014 AMENDED: APRIL 29, 2015
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2015
NEUROCRINE BIOSCIENCES, INC. INDUCEMENT PLAN ADOPTED: SEPTEMBER 15, 2014 AMENDED: OCTOBER 7, 2014
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2014
FINANCIAL STATEMENTS
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2009
Target Indication
NEUROCRINE BIOSCIENCES INC
Biotechnology
2009
Current assets
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2008
Target Indication
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2008
Target Indication
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2008
Target Indication
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2008
Target Indication
NEUROCRINE BIOSCIENCES INC
Biotechnology
NY
2008
Target Indication
NEUROCRINE BIOSCIENCES INC
Biotechnology
NY
2008
Current assets
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2007
Current assets
NEUROCRINE BIOSCIENCES INC
Biotechnology
DE
2007
Current assets
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2007
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2007
Current assets
NEUROCRINE BIOSCIENCES INC
Biotechnology
DE
2007
Current assets
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2007
Current assets
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2007
Current assets
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2007
Current assets
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2007
Current assets
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2007
Current assets
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2007
Target Indication
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2007
Current assets
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2006
Current assets
NEUROCRINE BIOSCIENCES INC
Biotechnology
2006
Current assets
NEUROCRINE BIOSCIENCES INC
Biotechnology
2006
Amended agreement with GlaxoSmithKline dated February 7, 2006
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2006
Target Indication
NEUROCRINE BIOSCIENCES INC
Biotechnology
2006
Exhibit No
NEUROCRINE BIOSCIENCES INC
Biotechnology
2006
Exhibit No
NEUROCRINE BIOSCIENCES INC
Biotechnology
DE
2006
Description of Exhibit
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2005
Description of Exhibit
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2005
EXHIBITS. The following exhibits are
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2005
Description of Exhibit
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2005
Description of Exhibit
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2005
Target Indication
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2005
Target Indication
NEUROCRINE BIOSCIENCES INC
Biotechnology
CA
2005